Resolution of 1-(4-amino-3-chloro-5-cyanophenyl)-2-bromo-1-ethanol by lipase mediated enantioselective alcoholysis, hydrolysis and acylation
摘要:
Resolution of 1-(4-amino-3-chloro-5-cyanophenyl)-2-bromo-1-ethanol has been achieved by ethanol enantio-selective lipase-catalysed alcoholysis, hydrolysis and acylation. Although a good enantioselectivity was observed in the three reactions, the best results were obtained by hydrolysis. This alpha-bromohydrin is an intermediate in the synthesis of a new adrenergic agent. (C) 1998 Elsevier Science Ltd. All rights reserved.
Resolution of 1-(4-amino-3-chloro-5-cyanophenyl)-2-bromo-1-ethanol by lipase mediated enantioselective alcoholysis, hydrolysis and acylation
摘要:
Resolution of 1-(4-amino-3-chloro-5-cyanophenyl)-2-bromo-1-ethanol has been achieved by ethanol enantio-selective lipase-catalysed alcoholysis, hydrolysis and acylation. Although a good enantioselectivity was observed in the three reactions, the best results were obtained by hydrolysis. This alpha-bromohydrin is an intermediate in the synthesis of a new adrenergic agent. (C) 1998 Elsevier Science Ltd. All rights reserved.
modulate GPCR signal transduction in such a way that desirable signals are enhanced to produce therapeutic effects while undesirable signals of the same GPCR are suppressed to avoid side effects. In the present study, we evaluated agonist bias for compounds developed along a drug discovery project of β2-adrenoceptor agonists. About 150 compounds, including derivatives of fenoterol, 2-amino-1-phenylethanol
[EN] NEW ETHANOLAMINE DERIVATIVES<br/>[FR] NOUVEAUX DERIVES D'ETHANOLAMINE
申请人:LABORATORIOS ALMIRALL, S.A.
公开号:WO1996031466A1
公开(公告)日:1996-10-10
(EN) A compound which is an ethanolamine derivative of formula (I), wherein R1 is a pyridyl or NR2R3 group, wherein R2 is hydrogen or a C1-C4 alkyl or methanesulphonyl group and R3 is a C2-C4 alkanoyl group, an unsubstituted phenyl group or a phenyl group substituted by a carbamoyl group; m is from 4 to 8; and n is 2 or 3; or a pharmacologically acceptable salt thereof, has agonist activity on the adrenergic $g(b)-receptors of the bronchus.(FR) La présente invention décrit un composé qui est un dérivé d'éthanolamine de formule (I), dans laquelle R1 est un pyridyle ou un groupe NR2R3, dans lequel R2 représente un hydrogène ou un alkyle C1-C4 ou un groupe méthanesulphuryle et R3 représente un groupe alkanoyle C2-C4, un groupe phényle non substitué ou un groupe phényle substitué par un groupe carbamoyle; m est compris entre 4 et 8; et n vaut 2 ou 3; ou un de ses sels pharmaceutiquement acceptables, comporte une activité agoniste sur les récepteurs $g(b) adrénergiques des bronches.
Resolution of 1-(4-amino-3-chloro-5-cyanophenyl)-2-bromo-1-ethanol by lipase mediated enantioselective alcoholysis, hydrolysis and acylation
Resolution of 1-(4-amino-3-chloro-5-cyanophenyl)-2-bromo-1-ethanol has been achieved by ethanol enantio-selective lipase-catalysed alcoholysis, hydrolysis and acylation. Although a good enantioselectivity was observed in the three reactions, the best results were obtained by hydrolysis. This alpha-bromohydrin is an intermediate in the synthesis of a new adrenergic agent. (C) 1998 Elsevier Science Ltd. All rights reserved.